I-Mab
NASDAQ:IMAB

Watchlist Manager
I-Mab Logo
I-Mab
NASDAQ:IMAB
Watchlist
Price: 0.9397 USD -2.01% Market Closed
Market Cap: 76m USD
Have any thoughts about
I-Mab?
Write Note

I-Mab
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

I-Mab
Accumulated Depreciation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
I-Mab
NASDAQ:IMAB
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Accumulated Depreciation
-ÂĄ2B
CAGR 3-Years
-59%
CAGR 5-Years
-94%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Accumulated Depreciation
-ÂĄ787.8m
CAGR 3-Years
-30%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Accumulated Depreciation
-ÂĄ1.3B
CAGR 3-Years
-12%
CAGR 5-Years
-12%
CAGR 10-Years
-25%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Accumulated Depreciation
-ÂĄ1.5B
CAGR 3-Years
-38%
CAGR 5-Years
-38%
CAGR 10-Years
-33%
Imeik Technology Development Co Ltd
SZSE:300896
Accumulated Depreciation
-ÂĄ159.8m
CAGR 3-Years
-70%
CAGR 5-Years
-65%
CAGR 10-Years
N/A
No Stocks Found

I-Mab
Glance View

Market Cap
76m USD
Industry
Biotechnology

I-Mab operates as a clinical stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-01-17.

IMAB Intrinsic Value
0.7454 USD
Overvaluation 21%
Intrinsic Value
Price

See Also

Back to Top